The European pond turtle (Emys orbicularis) is an endangered species occurring in large parts of Europe, northern Africa, and western Asia. The species is subject to a number of translocation-based conservation initiatives that rely on collections from private and institutional breeding facilities. So far, relatively little work has been done on infectious diseases in this species. During routine health screening in two European pond turtle collections, one of reintroduced turtles in France and one of head-started juveniles in Germany, oral and cloacal swabs from 47 clinically healthy European pond turtles were screened for the presence of adenoviruses, herpesviruses, ranaviruses, and mycoplasma by PCR. Adenoviruses and mycoplasma were detected in 35 (74.5%) and 12 (25.5%) turtles, respectively, whereas no ranaviruses or herpesviruses were detected in any tested individuals. Both adenoviruses and mycoplasma were concurrently found in 11 (23.4%) individuals, but there was no significant relationship between infection with these two pathogens. Sequencing of several of the PCR products revealed two different adenoviruses, the majority (90% of the 20 sequenced) being a novel testadenovirus (Emys testadenovirus 1), while a virus closely related to the previously described box turtle testadenovirus 1 was found in two animals. The mycoplasmas were closely related to previously described mycoplasmas from emydid turtles. Additional work is needed to understand the diversity and impacts of viral and bacterial pathogens on European pond turtles. Systematic standard testing and quarantine protocols should be established for this species, especially for translocation-based conservation initiatives.